Atlas Trials

A Phase I Study to Evaluate Safety and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356

Clinical trial NCT05574166 · TERMINATED

Trial details

NCT number
NCT05574166
Sponsor
Shin Poong Pharmaceutical Co. Ltd.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
AtherosclerosisIschemic Stroke
Start date
2021-01-03
Primary completion
2021-10-28
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.